1.512EUR-1.18%Mkt Cap: 164.23M $P/E: —1d ago
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for …
Industry Peers
Medical Instruments & Suppliesvs Medical Instruments & Supplies
P/B
Avg
1M Perf
Higher
Indicators:|
Key Statistics
Company
Market Cap164.23M $
Enterprise Value82.79M $
Revenue (TTM)16.66M $
Gross Profit6.88M $
Net Income (TTM)-97.92M $
Revenue/Share0.4207 USD
Last Price1.512 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees153
CountryBE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.22
PEG—
EV/EBITDA-0.93
EV/Revenue4.97
P/S9.86
P/B1.84
EPS (TTM)-2.13
EPS (Forward)-0.47
52W Range
1.2563% of range8.870
52W High8.870 EUR
52W Low1.256 EUR
Profitability
Gross Margin63.13%
Oper. Margin-321.72%
EBITDA Margin0.00%
Profit Margin-899.05%
ROE-183.36%
ROA-76.04%
Growth
Revenue Growth498.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-74.98M $
CapEx (TTM)4.10M $
FCF Margin-298.63%
FCF Yield-30.30%
Net Debt11.03M $
Net Debt/EBITDA-0.12
Balance Sheet
Debt/Equity0.82
Current Ratio0.99
Quick Ratio0.85
Book Value/Sh0.8220 EUR
Cash/Share0.5940 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.800 EUR
Upside (mean)+283.6%
Target Range3.500 EUR – 8.300 EUR
€3.500+283.6% to mean€8.300
# Analysts3
Ownership
Shares Out.99.93M
Float29.70M
Insiders33.61%
Institutions26.85%
Technical
SMA 502.196 (-31.1%)
SMA 2003.518 (-57.0%)
Beta0.89
S&P 52W Chg20.05%
Avg Vol (30d)281.32K
Avg Vol (10d)179.28K
Technical Indicators
RSI (14)35.0
MACD-0.2324
MACD Signal-0.2669
MACD Hist.+0.0345
BB Upper2.523 EUR
BB Middle1.641 EUR
BB Lower0.7598 EUR
BB Width107.41%
ATR (14)0.1398 EUR
Vol Ratio (20d)0.24x